Regulation & policy

NutraCast: Beyond the COA – Testing blind spots put brands at risk

As retailers and regulators demand greater confidence in product quality, brands are taking a closer look at what their testing actually proves.

Opinion piece

Drug preclusion: Consider the source

CRN, CHPA and AHPA are celebrating H.R. 10336 as a balanced compromise. But in the pursuit of regulatory certainty, has part of the supplement industry agreed to permanently enshrine the very pharmaceutical gatekeeping mechanism it has spent years fighting?

NI+Botanical safety: Is Article 8 fit for purpose?

In the European Union, Article 8 procedures are used to evaluate, restrict and remove potentially unsafe ingredients from the supplement market, but its use in recent years has been the subject of controversy.

NI+Botanical Safety Consortium: Tools needed to decode the ‘most creative synthetic factories’

Botanicals are complex mixtures of chemical compounds with potent pharmacological and toxicological properties. They have been used for centuries as both food and medicine for therapeutic benefits but can also present safety risks.

NI+California signs restrictive supplement bill into law, industry concerned

California Governor Gavin Newsom has signed AB 2030 into law, imposing new age restrictions on a broad array of dietary supplements marketed or represented for weight loss or muscle building as part the state’s holistic healthcare strategy.

SANS USA moves to Dallas for 2027

The Sports & Active Nutrition Summit USA (SANS USA) is heading to Dallas in 2027 after two consecutive sold-out editions in San Diego.

ASA calls out health claim breaches as food brands become function focused

Food brands’ increasing use of health and nutrition messaging reflects a broader trend of ‘aggressive marketing’ across the UK, a legal expert has warned after the ASA called out Whitworths Ltd for claiming nuts could extend life and reduce the risk of...

Across the Nutraverse: NZ claims for exports, Amway vs FTC, Bio-K+ in the UK, Better Menopause, krill oil pulled from Aus retailers

This week’s brief tracks news that highlights the industry’s shift towards a future defined by stronger regulatory oversight, greater scientific substantiation, export-focused regulatory reform, and growing sustainability expectations.    

Alice Mushrooms case tests limits of ingredient substantiation

A recent case decision offers a closer look at how the National Advertising Division (NAD) approaches ingredient-level research when companies make claims for multi-ingredient products, including when that evidence can be extrapolated to the finished...

NutraIngredients at 25

NutraCast: NutraIngredients at 25 | Stephen Daniells reflects on two decades of change

As NutraIngredients celebrates 25 years, Global Editor-in-Chief Stephen Daniells, PhD, looks back at the 20+ years he has been with the publication. From the early days of digital publishing to the rise of social media, podcasts, video and now AI,...

New Jersey legislator introduces restrictive supplements bill

A lawmaker in New Jersey has filed a bill to prohibit the sale of weight loss and muscle building products to minors, part of a broader trend of state-level efforts to restrict youth access to certain dietary supplements.

NI+Kiwi government proposes new rules for supplement exports, industry voices support

New Zealand’s Food Safety Minister Andrew Hoggard has proposed loosening requirements for dietary supplements meant for export—a move that the local industry believes would be a game-changer.

Amway agrees $225 million settlement with FTC over alleged deceptive business practices

Multilevel marketing giant Amway and two Amway licensees will pay $225 million to resolve allegations from the Federal Trade Commission and the state of Washington for alleged unfair and deceptive tactics.

What is the industry getting wrong? FNIS leaders weigh in

From social media pseudoscience and influencer culture to industry advocacy and trend-chasing, Future Nutra Innovation Summit (FNIS) attendees outlined where they see gaps — and what could change them.

Regulatory update

NI+Brazil authorizes new supplement ingredients and health claims

Brazil’s National Health Surveillance Agency (ANVISA) has updated its regulatory framework for dietary supplements, adding new authorized ingredients, establishing dosage limits and introducing new health claims that manufacturers can use on supplement...

NI+Industry, research experts surprised, disappointed at TGA’s Andrographis removal

Australia’s health supplement and herbalist associations, along with a leading botanical research expert, have voiced disappointment over the Therapeutic Goods Administration’s (TGA) decision to remove Andrographis from listed medicines, asking why...

NI+‘Turning point’ for CBD as EFSA publishes first positive safety opinion

The European Food Safety Authority (EFSA) has published its first positive safety opinion for a CBD novel food application, marking a turning point for the industry, but concerns remain over the commercial viability of its imposed low daily limit.

Nestlé Russia under state control: What happens next?

As the dust settles on Russia’s takeover of Nestlé’s local operations, analysts warn the move could reshape how multinationals assess risk in the country

NI+UK food industry must band together to protect the health of the nation, experts say

With 9 million UK citizens heading for chronic disease by 2040, health has become a central focus for consumers, with 89% of households now prioritizing health and well-being, according to data from NielsenIQ (NIQ).

Andrographis no longer allowed in new listed medicines sold in Australia

Andrographis paniculata is no longer allowed in new listed medicines sold in Australia, starting from Sept. 17, 2026, the local regulator, the Therapeutic Goods Administration (TGA), announced. Sponsors of existing Andrographis products will be receiving...

What will define the next era of nutra? Industry leaders weigh in at FNIS

The next five years of nutraceutical innovation could be defined less by a single breakthrough ingredient and more by the convergence of technology, nature, new delivery formats and changing consumer behavior, according to industry leaders at the Future...

NI+Botanical adulteration on the rise despite 15 years of industry action

Adulteration is one of the most significant and persistent issues facing the botanical industry, and the issue appears to be on the rise, exacerbated by supply chain pressures, trade wars and climate change.

NI+FSA signals ‘major milestone’ in CBD novel food process: Should industry raise its hopes?

The UK Food Standards Agency (FSA) has described its recommendation to authorize the country’s first CBD novel food applications as a “major milestone”, but industry observers question whether the move marks a genuine regulatory breakthrough or simply...

NI+New bill seeks to fix drug preclusion provision to boost dietary supplement innovation

Congresswoman Diana Harshbarger (R-TN) introduced the Dietary Supplement Innovation Act with the aim of modernizing the Food and Drug Administration’s (FDA) drug preclusion provision, a move that has been welcomed by dietary supplement trade associations.

NI+Gnosis secures EFSA approval for novel glutathione form

EFSA has published a positive safety opinion on S-acetyl glutathione (SAG), a chemically modified version of glutathione designed to enhance bioavailability.

Regulatory review: Ingredients safety re-evaluation, NMN product naming and more

South Korea’s Ministry of Food and Drug Safety’s (MFDS) re-evaluation of functional ingredients such as bilberry extract and Australia’s Therapeutic Goods Administration’s (TGA) guidance on NMN product naming are some of the latest updates in this...

NI+Luxembourg introduces new MPLs for vitamins and minerals in supplements

Luxembourg has updated its food supplement regulations, setting new maximum permitted limits (MPLs) for certain vitamins and minerals used in food supplements.

NI+Could disappearing heritage diets hold new clues for nutrition innovation?

A newly launched global research initiative is investigating how disappearing heritage diets influence disease, metabolism, immunity and the microbiome, and whether those insights could lead to new health interventions.

NI+EHPM calls for a pragmatic approach to PPWR implementation for food supplements

The European Federation of Health Product Manufacturers (EHPM) has published a new position paper setting out the food supplement sector’s key concerns and recommendations regarding the implementation of the Packaging and Packaging Waste Regulation (PPWR).

NI+Bilberry extract and lactoferrin among 10 ingredients under review in Korea

South Korea’s Ministry of Food and Drug Safety (MFDS) has announced that it is re-evaluating the safety and functionality claims of bilberry extract, lactoferrin and eight other ingredients next year. Companies marketing these ingredients have until Dec....

One Health action plan extension puts nutrition and environmental resilience on agenda

The global One Health Joint Plan of Action (OH JPA) has been extended to 2029, giving governments and industry stakeholders three additional years to coordinate action across human, animal, food and environmental health.

NI+Science vs politics: Kiwi’s long road to EU health-claim approval

It took four years after Europe’s food-safety scientists backed green kiwifruit’s digestive-health claim for regulators in Brussels to approve it, raising the bigger question: What happens when the science is settled, but the politics are not?

NI+More protein, more fiber, more questions: What happens to gut health?

Protein and fiber are having a moment, and consumers are being encouraged to get more of both, from fortified foods and functional products to social-media trends and new approaches to weight management.

NI+Mexico updates additives framework, tightens maximum limits

Mexico’s Ministry of Health has published a new agreement governing additives and processing aids in foods, beverages and dietary supplements, replacing the 2012 framework and introducing new maximum limits and phased transition periods for industry.

NI+Caelus next-gen live commensal bacterium gains EU Novel Food safety approval

A freeze-dried form of the gut bacterium Anaerobutyricum soehngenii CH106, developed by Caelus Life Sciences, has become the first live, gut-native bacterium of its kind to receive a positive EFSA safety opinion under the EU Novel Food Regulation.

NutraCast: On the coca trail with the Medicine Hunter

For centuries, coca leaf has played an important cultural and traditional role in the Andes. But outside South America, the plant is far more likely to be associated with one thing: cocaine. So what happens when we separate the coca leaf from the drug...

FDA wants more GRAS oversight – but can it handle the workload?

FDA wants companies to notify the agency when they determine food ingredients are Generally Recognized As Safe. But with hundreds of potential notifications and fewer staff, questions remain over whether FDA has the resources to review them

NI+Supplements 101: What are peptides?

The surge in GLP-1 drug use has brought peptides from a niche research area into the mainstream, sparking growing interest across nutrition and health, but confusion remains about what they are and how they are regulated.

NI+Senator’s inquiry questions kratom industry’s influence on Trump administration

An inquiry launched by Sen. Ron Wyden, the Senate Finance Committee’s ranking Democrat, is examining whether the kratom industry’s financial ties to members of the Trump administration have influenced federal policy.

B12 campaign calls on industry to tackle UK awareness gap

The UK’s B-12 Alliance will take to parliament on September 10 as part of its campaign to raise awareness of widespread vitamin B12 deficiency and improve diagnosis and treatment in the UK.

NI+Australia’s TGA releases guidance on NMN, NAD+ and NADH product naming

Australia’s Therapeutic Goods Administration (TGA) has released guidance on how NMN, NAD+, NAD and NADH can be represented in health supplements, with implications for naming, labeling and advertising requirements.

NI+The overproteinification of everything? Protein push in new dietary guidelines raises evidence and access questions

The 2025–2030 Dietary Guidelines for Americans elevate protein with a 1.2 to 1.6 g/kg/d intake range, opening new opportunities for the nutrition sector while drawing attention to the science, cost, practicality and potential risks underlying the...

When the influencer isn’t real: AI amplifies familiar supplement advertising risks

Synthetic spokespeople may be new, but industry experts say brands remain responsible for substantiated claims, truthful endorsements and transparent marketing.

NI+Timeline: How turmeric supplements brought bioavailability and idiosyncrasy into regulatory focus

Regulatory warnings about rare cases of liver injury linked to turmeric supplementation are mounting, as expert committees continue to raise questions about the cause and source of potential toxicity of an herb consumed by millions of people worldwide.

NutraCast: ‘It can be terrifying’: Tariffs, freight and geopolitics are squeezing the supplement supply chain

The dietary supplement industry is facing a new layer of supply-chain uncertainty as geopolitical tensions, tariffs, energy prices and freight disruptions ripple through the global ingredient market.

Heidi Overton nominated to lead FDA as supplement industry weighs ‘blank slate’

Dr. Heidi Overton was nominated by President Donald Trump to lead the Food and Drug Administration, the White House announced Wednesday.

EU Novel Food Catalog update on Echinacea exposes lack of clarity

The EU has confirmed that traditional Echinacea roots, herbs and teas are non-novel, but uncertainty remains around flowers, whole-plant preparations and the species Echinacea pallida.

Qunol faces class action over omega-3 claims

Quten Research Institute is facing a proposed class action alleging that its Qunol Ultra Omega-3 Fish Oil contains less omega-3 than the 1,000 mg advertised on the product label.

NI+‘Subscription trap’ crackdown accelerated: What does it mean for UK supplement brands?

The UK’s new Prime Minister, Andy Burnham, has announced the early introduction of new rules on subscription traps, with implications for supplement and health brands.

Q&A: How wearables are pushing supplement brands into new regulatory territory

Connected wellness products offer supplement companies opportunities to reach beyond traditional categories, but that move may also expose them to new safety requirements and closer regulatory scrutiny.